221 related articles for article (PubMed ID: 6280082)
1. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
[TBL] [Abstract][Full Text] [Related]
2. Survival of lung cancer patients treated with BCG and/or a soluble BCG fraction (F70) after surgery, radiotherapy and chemotherapy.
Hadźiev S; Kavaklieva-Dimitrova J; Mandulova P; Madźarova S; Spassova M
Neoplasma; 1980; 27(1):83-94. PubMed ID: 7374861
[TBL] [Abstract][Full Text] [Related]
3. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
[TBL] [Abstract][Full Text] [Related]
4. [Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types].
Fujisawa T; Yamaguchi Y
Gan No Rinsho; 1983 Oct; 29(12):1409-16. PubMed ID: 6315989
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic and therapeutic approach to lung neoplasms. Departmental experience at the Mestre Hospital].
Nascimben O; Schiavon F; Pagan V; Giannico S; Agazia L; Turcato G; Polico R; Idi MB; Stea L; Conte G
Radiol Med; 1988 May; 75(5):534-9. PubMed ID: 2453897
[TBL] [Abstract][Full Text] [Related]
6. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
Warren SE; Crispen RG; Nika B
Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
[TBL] [Abstract][Full Text] [Related]
7. [Multidisciplinary treatment of lung cancer].
Ohta M
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1146-52. PubMed ID: 2997500
[TBL] [Abstract][Full Text] [Related]
8. [Role of immunotherapy in the combined treatment of lung cancer].
Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
[No Abstract] [Full Text] [Related]
9. [Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung].
Fujisawa T
Gan To Kagaku Ryoho; 1985 Jan; 12(1):13-20. PubMed ID: 2981513
[TBL] [Abstract][Full Text] [Related]
10. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
[TBL] [Abstract][Full Text] [Related]
11. [Lung cancer in the young adult and results of surgical treatment].
Ding JA
Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):67-9. PubMed ID: 3015535
[TBL] [Abstract][Full Text] [Related]
12. Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guérin.
Grant SC; Kris MG; Houghton AN; Chapman PB
Clin Cancer Res; 1999 Jun; 5(6):1319-23. PubMed ID: 10389914
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of combination therapy for 252 patients of lung cancer with brain metastasis].
Zhang S; Yang X; Zhao A
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Aug; 22(8):475-7. PubMed ID: 11776562
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung: results of a prospective randomized trial.
Matthay RA; Mahler DA; Beck GJ; Loke J; Baue AE; Carter DC; Mitchell MS
Cancer Res; 1986 Nov; 46(11):5963-8. PubMed ID: 3530442
[TBL] [Abstract][Full Text] [Related]
15. Adverse effect of intrapleural Corynebacterium parvum as adjuvant therapy in resected stage I and II non-small cell carcinoma of the lung. Ludwig Lung Cancer Study Group.
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):842-7. PubMed ID: 2860271
[TBL] [Abstract][Full Text] [Related]
16. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.
Chen KY; Chang CH; Yu CJ; Kuo SH; Yang PC
Cancer; 2005 Jun; 103(12):2566-74. PubMed ID: 15852359
[TBL] [Abstract][Full Text] [Related]
17. Combined modality therapy of lung cancer.
Livingston RB
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
[TBL] [Abstract][Full Text] [Related]
18. Limited squamous cell carcinoma of the lung: a Southwest Oncology Group randomized study of radiation with or without doxorubicin chemotherapy and with or without levamisole immunotherapy.
White JE; Chen T; Reed R; Mira J; Stuckey WJ; Weatherall T; O'Bryan R; Samson MK; Seydel HG
Cancer Treat Rep; 1982 May; 66(5):1113-20. PubMed ID: 7044532
[TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N
Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650
[TBL] [Abstract][Full Text] [Related]
20. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]